检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《临床肿瘤学杂志》1998年第1期42-44,共3页Chinese Clinical Oncology
摘 要:目的:为探讨突变型P53蛋白、PCNA(增殖细胞核抗原)的表达与肺癌病理组织学的关系.方法:应用免疫组化ABC法检测112例原发性肺癌的P53蛋白、PCNA的表达.结果:①突变型P53表达的阳性率为45%;②突变型P53与PC-NA的表达关系密切,PCNA强阳性的P53强阳性率为86%,显著高于其他组(P<0.01);③P53强阳性率、PCNA强阳性率均以腺癌组为最低(P<0.05);④P53、PCNA的表达与肺癌分期间的关系不密切(P>0.05).结论:提示突变型P53蛋白、PCNA的表达可作为肺癌患者预后判断的客观指标.Purpose:To study the relation of the expression of P53 protein and proliferation cell nuclear antigen(PCNA)to the clinical and pathological behavior. Methods:By using immunohistochemical ABC method. Results; (1) Overexpression of P53 protein can be found in 45%of the lung cancers . (2) P53 Overexpression was related to the expression fo PCNA,P53 strong posi-tive rates were significant higher in PCNA strong positive groups(86%)than in other ones(P<0. 01). (3) The strong positive rates of P53 protein and PCNA were the most lower in the adenocarcinoma groups(P<0. 05). (4) Overexpression of P53 protein and PCNA were not associated with the clinical stages of the lung cancer(P<0. 05). Conclusion:This study indicates that the Overexpression of P53 protein and PCNA could be used as the useful prognosis factors for the patients with lung cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145